Pirepemat
Pirepemat (IRL752) is a cortical-preferring catecholamine enhancer used in cognitive research, particularly for Parkinson's disease. It is applied in both in vitro binding studies and in vivo models to investigate mechanisms of cognitive impairment and potential therapeutic pathways.
Product Specifications
CAS Number
1227638-29-0
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
CO[C@@]1 (CCNC1) c1cccc (F) c1F
Molecular Formula
C11H13F2NO
Molecular Weight
213.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FAB1850RR-100UG 100 µg
Human NKp46/NCR1 Alexa Fluor 647 MAb (Clone 195314R)
Sign In for Pricing
View Details 
224759-01 50 µL
P38 (Mitogen-Activated Protein Kinase 14, MAP Kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-Binding Protein, CSAID-Binding Protein, CSBP, MAP Kinase MXI2, MAX-interacting Protein 2, Mitogen-Activated Protein Kinase p38 alpha, MAP Kinase p38 alpha, Stress-Activated Protein Kinase 2a, SAPK2a, MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A) discontinued
Sign In for Pricing
View Details 224759-02 100 µL
P38 (Mitogen-Activated Protein Kinase 14, MAP Kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-Binding Protein, CSAID-Binding Protein, CSBP, MAP Kinase MXI2, MAX-interacting Protein 2, Mitogen-Activated Protein Kinase p38 alpha, MAP Kinase p38 alpha, Stress-Activated Protein Kinase 2a, SAPK2a, MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A) discontinued
Sign In for Pricing
View Details 